Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

113 projects found matching your search criteria :

  1. On the trail of Vulnerability and Resilience: miRNA regulated Synaptic Protein Palmitoylation as the Basis of Stress Res...

    Call: OPUS 29 , Panel: NZ5

    Principal investigator: prof. Jakub Mateusz Włodarczyk

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  2. Immersive virtual reality therapy combined with guided breathing exercises as a supportive intervention for reducing dep...

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Magdalena Anna Nowak

    Politechnika Opolska

  3. Identification of hippocampal impairments and sex differences in AMOTL1 KO mice.

    Call: SONATA 20 , Panel: NZ3

    Principal investigator: dr Przemysław Duda

    Sieć Badawcza ŁUKASIEWICZ - PORT Polski Ośrodek Rozwoju Technologii

  4. Modulation of 5-HT7 receptor signaling as common mechanism involved in the long-lasting antidepressant effects of typica...

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Barbara Wanda Chruścicka-Smaga

    Instytut Farmakologii PAN

  5. "Integrated Fixed-Dose Combination Drugs in Depression Therapy: A New Standard of Treatment and Mechanism of Action Stud...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: prof. Gabriel Piotr Nowak

    Instytut Farmakologii PAN

  6. Mechanisms of Antidepressant Action of Psilocybin: The Role of 5-HT2B-5-HT1A Receptor Dimerization and GSK-3β Activation...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: dr hab. Agata Faron-Górecka

    Instytut Farmakologii PAN

  7. Gut microbiota and their neuroactive metabolites in the development of mood disorder in PCOS women. Identification role ...

    Call: PRELUDIUM 23 , Panel: NZ9

    Principal investigator: Joanna Maria Pieczyńska-Zając

    Uniwersytet Przyrodniczy w Poznaniu

  8. Anti-neuroinflammatory and antidepressant activities of mycelial in vitro cultures of selected edible mushrooms enriched...

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Jan Patryk Lazur

    Uniwersytet Jagielloński

  9. The Spanish Civil War, (Un)Grievable Lives, and Mnemonic Solidarity in 21st-Century Canadian Fiction

    Call: OPUS 27 , Panel: HS2

    Principal investigator: prof. Anna Branach-Kallas

    Uniwersytet Mikołaja Kopernika

  10. Role of Astrocytes in Chronic Stress Resilience

    Call: OPUS 26 , Panel: NZ4

    Principal investigator: dr Piotr Marian Michaluk

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  11. Optogenetic and chemogenetic identification of brain circuits and cellular mechanisms underlying antidepressants resista...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN

  12. Speech and multimodal resources in social interactions of students with invisible mental disabilities

    Call: SONATA BIS 13 , Panel: HS2

    Principal investigator: dr Agnieszka Sowińska

    Uniwersytet Mikołaja Kopernika, Wydział Humanistyczny

  13. The cross-talk between 5-HTR2A and mGluR2 as a window for antidepressant effects of psilocybin.

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: prof. Andrzej Mikołaj Pilc

    Instytut Farmakologii PAN

  14. Plasticity of neuroanatomically identified synaptic inputs and functions of the dorsal raphe nucleus in an animal model ...

    Call: OPUS 25 , Panel: NZ4

    Principal investigator: prof. Krzysztof Tokarski

    Instytut Farmakologii PAN

  15. Targeting the serotonin 5-HT7 receptor in a search for new strategies of mental disorders treatment

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Patryk Pyka

    Uniwersytet Jagielloński, Collegium Medicum

  16. The allostatic load concept as an attempt to understand biological and psychopathological consequences of the refugee cr...

    Call: PRELUDIUM 21 , Panel: NZ5

    Principal investigator: Julian Piotr Maciaszek

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Lekarski

  17. Genetics of GR-dependent behavioral traits in humans

    Call: OPUS 23 , Panel: NZ5

    Principal investigator: dr hab. Michał Korostyński

    Instytut Farmakologii PAN

  18. Socio-political radicalization of the Polish province during the Great Depression and its consequences. The case of Wiel...

    Call: OPUS 23 , Panel: HS3

    Principal investigator: dr hab. Grzegorz Roman Krzywiec

    Instytut Historii im. Tadeusza Manteuffla PAN

  19. Enhancement of antidepressant therapy by combined administration of hyperforin and ketamine: behavioral and molecular st...

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Bartłomiej Pochwat

    Instytut Farmakologii PAN

  20. Translational and interdisciplinary investigation of phenotypes of reinforcement sensitivity as predictors of the respon...

    Call: OPUS 22 , Panel: HS6

    Principal investigator: dr hab. Rafał Ryguła

    Instytut Farmakologii PAN

  21. The role of the immune checkpoints in the pathomechanism of depressive disorders.

    Call: OPUS 22 , Panel: NZ6

    Principal investigator: prof. Marta Wanda Kubera

    Instytut Farmakologii PAN

  22. Novel Point-of care-diagnostic devices for monitoring the concentration of lithium and creatinine in patients during the...

    Call: SONATA 17 , Panel: ST4

    Principal investigator: dr Justyna Zofia Paluch

    Uniwersytet Jagielloński, Wydział Chemii

  23. Do astrocytes control synaptic connectivity in neural circuits relevant for psychiatric disorders?

    Call: OPUS 21 , Panel: NZ3

    Principal investigator: dr Michał Wiesław Ślęzak

    Sieć Badawcza ŁUKASIEWICZ - PORT Polski Ośrodek Rozwoju Technologii

  24. Transparency, integrity and independence in clinical research in psychology

    Call: OPUS 21 , Panel: HS6

    Principal investigator: dr Bartosz Helfer

    Uniwersytet Wrocławski, Wydział Nauk Historycznych i Pedagogicznych

  25. The impact of pregnant rat dietary supplementation with Lactobacillus rhamnosus JB-1 bacteria on depression-related symp...

    Call: PRELUDIUM 20 , Panel: NZ4

    Principal investigator: dr Agata Chudzik

    Uniwersytet Medyczny w Lublinie

  26. Interplay between neuroplasticity and CC/CXC chemokine inflamatory pathways in depression.

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Tomasz Adam Śliwiński

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  27. Impact of pharmacogenetic profiles on depression treatment outcomes

    Call: SONATINA 5 , Panel: NZ2

    Principal investigator: dr Małgorzata Maria Borczyk

    Instytut Farmakologii PAN

  28. The effect of omega-3 fatty acid-enriched diet on the myelination impairment and the depression-like phenotype induced b...

    Call: SONATA 16 , Panel: NZ5

    Principal investigator: dr Irena Maria Smaga-Maślanka

    Instytut Farmakologii PAN

  29. Prenatal exposure to glucocorticoids as a risk factor for depression - the importance of epigenetic mechanisms in the br...

    Call: SONATA 16 , Panel: NZ7

    Principal investigator: dr Katarzyna Elżbieta Głombik

    Instytut Farmakologii PAN

  30. Neurochemical basis of antidepressive properties of psychedelics in rodent model of depression

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: prof. Krystyna Czesława Gołembiowska

    Instytut Farmakologii PAN

  31. Metabolic Chronopathology in Depression: Functional Astrocyte-Neuron Interactions in the Cellular Model of Glucocorticoi...

    Call: POLS , Panel: NZ3

    Principal investigator: dr Michał Wiesław Ślęzak

    Sieć Badawcza ŁUKASIEWICZ - PORT Polski Ośrodek Rozwoju Technologii

  32. Combined administration of muscarinic receptor antagonists and group II/III metabotropic glutamate (mGlu) receptor ligan...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: prof. Andrzej Mikołaj Pilc

    Instytut Farmakologii PAN

  33. Zinc deficient diet as a trigger for treatment-resistant depression in chronically stressed mice. Understanding the mech...

    Call: OPUS 19 , Panel: NZ5

    Principal investigator: dr hab. Bernadeta Szewczyk

    Instytut Farmakologii PAN

  34. Relationship between depression, anxiety and Social Networking Sites addiction: The role of Fear of Missing Out and pref...

    Call: PRELUDIUM 19 , Panel: HS6

    Principal investigator: Julia Maria Balcerowska

    Uniwersytet Gdański, Wydział Nauk Społecznych

  35. Influence of modified maternal diet on the phenotype of offspring: behavioral and molecular correlations

    Call: ETIUDA 8 , Panel: NZ7

    Principal investigator: Kinga Eryka Gawlińska

    Instytut Farmakologii PAN

  36. Neuronal and behavioral mechanisms of emotion regulation and autobiographical memory in borderline personality disorder ...

    Call: ETIUDA 8 , Panel: HS6

    Principal investigator: Maria Karolina Kulesza

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  37. Investigation of molecular mechanisms of rapid antidepressant action of NLX-101, a biased agonist of the 5-HT1A receptor...

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN

  38. Targeting senescent brain cells to improve cognitive function in animal models of ageing and depression

    Call: OPUS 18 , Panel: NZ4

    Principal investigator: prof. Ewa Zofia Sikora

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  39. Endocannabinoid regulation of the motivational tone at the mesolimbic system driven by inflammation

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: prof. Katarzyna Maria Starowicz-Bubak

    Instytut Farmakologii PAN

  40. Dual action of HBK-15 – unraveling cellular mechanisms underlying its fast antidepressant-like and procognitive effects...

    Call: SONATA BIS 9 , Panel: NZ7

    Principal investigator: dr hab. Karolina Anna Pytka

    Uniwersytet Jagielloński, Collegium Medicum

  41. Therapeutic potential of biased 5-HT7 receptor ligands in the treatment of depression

    Call: OPUS 17 , Panel: NZ7

    Principal investigator: prof. Paweł Maria Zajdel

    Uniwersytet Jagielloński, Collegium Medicum

  42. The labeling effect in prosocial behavior toward out-group members in the example of people diagnosed with depression

    Call: PRELUDIUM 17 , Panel: HS6

    Principal investigator: Katarzyna Kulwicka

    Szkoła Wyższa Psychologii Społecznej w Warszawie, Wydział Psychologii we Wrocławiu

  43. Seeing the world thorough rose colored glasses: How acute aerobic exercise influences emotional processing and emotional...

    Call: SONATINA 3 , Panel: HS6

    Principal investigator: dr Tomasz Stanisław Ligęza

    Uniwersytet Jagielloński, Wydział Filozoficzny

  44. Thymol-derived 1,3,5-triazines, the non-indole and non-sulfone 5-HT6 receptor ligands, as a starter in search for an inn...

    Call: OPUS 16 , Panel: NZ7

    Principal investigator: prof. Jadwiga Handzlik

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  45. Novel pharmacological strategies for the treatment of depression

    Call: OPUS 16 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Młyniec

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  46. Novel hybrid 5-HT6 serotonin receptor and SERT transporter ligands as a therapeutic perspective of behavioural and cogni...

    Call: SONATA 14 , Panel: NZ7

    Principal investigator: dr Agata Siwek

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  47. Small Changes - Huge Impact: The role of S-palmitoylation and S-nitrosylation interplay in the mice model of depression

    Call: SONATA BIS 7 , Panel: NZ4

    Principal investigator: dr hab. Jakub Mateusz Włodarczyk

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  48. Modulation of inflammatory processes using new agonists of the formyl peptide receptors ALX/FPR2 as a new therapeutic st...

    Call: HARMONIA 9 , Panel: NZ7

    Principal investigator: prof. Agnieszka Basta-Kaim

    Instytut Farmakologii PAN

  49. Effectiveness of self-affirming implementation intentions to reduce anxiety and depression, and improve well-being in ps...

    Call: PRELUDIUM 13 , Panel: HS6

    Principal investigator: Patryk Marek Łakuta

    Szkoła Wyższa Psychologii Społecznej w Warszawie, Wydział Psychologii

  50. Pharmacological and optogenetic investigation of the mechanism of action of Deep Brain Stimulation of the ventromedial p...

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN